Intuitive Surgical, Inc.Opportunity Rank #280(ISRG) Intrinsic Value & DCF Analysis (2026)
Current Price
$406.78
Last updated: Jul 13, 2026
Price vs Intrinsic Value
Fundamental Score
Weighted across 6 signals
Narrative Score
+2 vs previous
Trend Score
As of 2026-07-10
The intrinsic value of Intuitive Surgical, Inc. (ISRG) is estimated at $182.86 per share based on a 10-year discounted cash flow (DCF) analysis. At the current price of $406.78, the stock appears overvalued relative to its projected cash flow fundamentals. This estimate assumes a 6.32% long-term growth rate and a 10.45% discount rate, reflecting expected future free cash flow and cost of capital.
The intrinsic value of Intuitive Surgical, Inc. (ISRG) is estimated at $182.86 per share based on a 10-year discounted cash flow (DCF) analysis. At the current price of $406.78, the stock appears overvalued relative to its projected cash flow fundamentals. This estimate assumes a 6.32% long-term growth rate and a 10.45% discount rate, reflecting expected future free cash flow and cost of capital.Valuation Details
Capital Efficiency
The company is earning below its required return. This may indicate inefficient use of capital or excess cash that isn't being reinvested.
Fundamental Details
Narrative Details
Trend Details
Investment Coach
- Price moves to at least a mid-teens discount to fair value
- Sustained improvement in ROIC versus WACC spread
- Meaningful shifts in the narrative trend or score direction
Free Cash Flow (in millions)
How Intrinziq Estimates Fair Value
Intrinziq estimates Intuitive Surgical, Inc.'s intrinsic value using a discounted cash flow (DCF) model based on free cash flow trends and a market-based discount rate. The model projects future cash flows over ten years and discounts them using a market return assumption to estimate fair value.
Intuitive Surgical, Inc.Healthcare
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.